Publications by authors named "Patrick Ma"

Claim this Profile
T
The effect of oral belzutifan on retinal hemangioblastomas in von Hippel-Lindau syndrome.
Kirk A J Stephenson, Jennifer Y M Ling, Olubayo U Kolawole, Melanie O'Loughlin, Lica Chui, Maryam Soleimani, Patrick E Ma

Can J Ophthalmol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma.
Amin H Nassar, Chul Kim, Tolulope Adeyelu, Elias Bou Farhat, Hassan Abushukair, Kelsey Matteson, Yamato Takabe, Suresh Ramalingam, Sumaiya Alam, Maria Zurera Berjaga, Emanuele Claudio Mingo, Thomas U Marron, Khaled Alhamad, Unaiza Zaman, Mark Evans, Patrick C Ma, Matthew Lee, Raid Aljumaily

Nat Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 () Fusions.
Tejas Patil, Jessica J Lin, Parneet K Cheema, Daniel R Carrizosa, Mark E Burkard, Saiama N Waqar, Jessica R Bauman, Patrick C Ma, Jamal Misleh, Matthias Weiss, Maegan Deegan, Jonathan Kaufman

JCO Precis Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SCD1 Inhibition Blocks the AKT-NRF2-SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma.
Utsav Sen, Charles Coleman, Nishant Gandhi, Vrinda Jethalia, Deniz Demircioglu, Omar Hayatt, Patrick C Ma

Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceedings of the 1st biannual bridging the gaps in lung cancer conference.
Narjust Florez, Sandip P Patel, Heather Wakelee, Lyudmila Bazhenova, Erminia Massarelli, Jyoti Malhotra, Matthew Gubens, Patrick C Ma

Oncologist· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Nonsmall Cell Lung Cancer.
Alexander S Watson, Harris B Krause, Andrew Elliott, Alex Farrell, Stephen V Liu, Patrick C Ma

Clin Lung Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activation.
David Hsiehchen, Andrew Elliott, Joanne Xiu, Andreas Seeber, Wafik El-Deiry, Emmanuel S Antonarakis, Patrick C Ma, John Marshall

Cancer Cell· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative peripheral live single T-cell dynamic polyfunctionality profiling predicts lung cancer checkpoint immunotherapy treatment response and clinical outcomes.
Zuan-Fu Lim, Xiaoliang Wu, Lin Zhu, Heidar Albandar, Maria Hafez, Matthew Smolkin, Patrick C Ma

Transl Lung Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: The Immune Profiles of the Molecular Subtypes of EGFR-Mutant Lung Adenocarcinomas in a Large Real-World Cohort.
J Nicholas Bodor, Joanne Xiu, Vinicius Ernani, Supreet Kaur, Hirva Mamdani, Patrick C Ma, Margie L Clapper

Clin Lung Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumors.
Dan Morgenstern-Kaplan, Samuel A Kareff, Asaad Trabolsi, Estelamari Rodriguez, Harris Krause, Emmanuel S Antonarakis, Patrick C Ma

Oncologist· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling METex14+ non-small cell lung cancer (NSCLC): Impact of histology.
Jennifer A Marks, Nishant Gandhi, Balazs Halmos, Melina E Marmarelis, So Yeon Kim, Suresh S Ramalingam, Matthew J Oberley, Patrick C Ma

Lung Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors.
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, Guilherme Harada, Jessica K Lee, Malini M Gandhi, Marie-Anaïs Locquet, Emma Voligny, Zachary Zimmerman, Sumandeep Atwal, Magda Bahcall, Sumaiya Iqbal, Patrick C Ma, Mark M Awad

Cancer Discov· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex Difference in Disease-Related Adverse Events Post-Diagnosis of Lung Cancer Brain Metastases in Medicare Individuals ≥ 66 Years of Age.
Mantas Dmukauskas, Gino Cioffi, Kristin A Waite, Aaron G Mammoser, Andrew E Sloan, Patrick C Ma

Cancers (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers.
Maishara Muquith, Magdalena Espinoza, Andrew Elliott, Joanne Xiu, Andreas Seeber, Emmanuel S Antonarakis, Patrick C Ma, John Marshall

Nat Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With -Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review.
Jia Luo, Narjust Florez, Anjali Donnelly, Yanyan Lou, Kevin Lu, Patrick C Ma

JCO Precis Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in -Mutant Non-Small-Cell Lung Cancer.
Abdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, Asaf Maoz, Amin H Nassar, Mark M Awad, Patrick C Ma, Hirva Mamdani

JCO Precis Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two cases of ocular needle injury presenting with endophthalmitis in a Canadian inner-city population.
Amanda Schlenker, Anastasia Faggioni, Patrick Ma, Greg Moloney, Heather O'Donnell

Can J Ophthalmol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma.
Tao Guo, Shilei Zhao, Peng Wang, Xiaoyuan Xue, Yan Zhang, Patrick C Ma

Oncotarget· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Exon 14 Skipping Alterations (in NSCLC) and Identification of Potential Therapeutic Targets Using Whole Transcriptome Sequencing.
So Yeon Kim, Jun Yin, Stephen Bohlman, Phillip Walker, Sanja Dacic, Patrick C Ma

JTO Clin Res Rep· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities.
Roberta Esposito, Taisia Polidori, Dominik F Meise, Carlos Pulido-Quetglas, Panagiotis Chouvardas, Patrick C Ma, Ivan Martinez

Cell Genom· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Evanescent White Dot Syndrome following COVID-19 mRNA Vaccination in Two Patients.
Ebony Smith, Tuan Tran, Alex Gillies, Shanna Yeung, Patrick E Ma

Ocul Immunol Inflamm· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization and costs of epidermal growth factor receptor mutation testing and targeted therapy in Medicare patients with metastatic lung adenocarcinoma.
Chan Shen, Rolfy A Perez Holguin, Eric Schaefer, Shouhao Zhou, Chandra P Belani, Patrick C Ma

BMC Health Serv Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC).
Misako Nagasaka, Mohammad Fahad B Asad, Mohammed Najeeb Al Hallak, Md Hafiz Uddin, Ammar Sukari, Dan Magee, Hirva Mamdani, Patrick C Ma

Lung Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC.
Yayi He, Linsong Chen, Lishu Zhao, Shiying Dang, Guifeng Liu, Patrick C Ma

Theranostics· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Glembatumumab Vedotin in Patients With Advanced or Metastatic Squamous Cell Carcinoma of the Lung (PrECOG 0504).
Saad A Khan, Zhuoxin Sun, Suzanne Dahlberg, Jyoti Malhotra, Roger Keresztes, Patrick Ma, Suresh S Ramalingam

JTO Clin Res Rep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis